Multiple significant DEGs were observed, including CR2, MS4A1, IGLL1, RAG1, and SEMA3. Many DEGs were involved in B-cell receptor regulation and signaling, highlighting pathways that must be further explored to assess their significance in pediatric cancer development and outcomes. This evidence concerns the gene CR2 and cancer.